Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12


Neurofibromatosis 2 invasion of the internal auditory canal wall: clinical significance.

Doherty J, Go JL, Linthicum FH Jr.

Otol Neurotol. 2014 Oct;35(9):1662-8. doi: 10.1097/MAO.0000000000000494.


Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer.

Eder M, Neels O, Müller M, Bauder-Wüst U, Remde Y, Schäfer M, Hennrich U, Eisenhut M, Afshar-Oromieh A, Haberkorn U, Kopka K.

Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96. doi: 10.3390/ph7070779.


Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.

Westdorp H, Sköld AE, Snijer BA, Franik S, Mulder SF, Major PP, Foley R, Gerritsen WR, de Vries IJ.

Front Immunol. 2014 May 6;5:191. doi: 10.3389/fimmu.2014.00191. eCollection 2014. Review.


Current early diagnostic biomarkers of prostate cancer.

Qu M, Ren SC, Sun YH.

Asian J Androl. 2014 Jul-Aug;16(4):549-54. doi: 10.4103/1008-682X.129211. Review.


A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer.

Schäfer M, Bauder-Wüst U, Leotta K, Zoller F, Mier W, Haberkorn U, Eisenhut M, Eder M.

EJNMMI Res. 2012 Jun 6;2(1):23. doi: 10.1186/2191-219X-2-23.


Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection.

Xiao Z, Levy-Nissenbaum E, Alexis F, Lupták A, Teply BA, Chan JM, Shi J, Digga E, Cheng J, Langer R, Farokhzad OC.

ACS Nano. 2012 Jan 24;6(1):696-704. doi: 10.1021/nn204165v. Epub 2012 Jan 3.


Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression.

Yin L, Rao P, Elson P, Wang J, Ittmann M, Heston WD.

PLoS One. 2011;6(6):e21319. doi: 10.1371/journal.pone.0021319. Epub 2011 Jun 24.


HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.

Olson BM, Frye TP, Johnson LE, Fong L, Knutson KL, Disis ML, McNeel DG.

Cancer Immunol Immunother. 2010 Jun;59(6):943-53. doi: 10.1007/s00262-010-0820-6. Epub 2010 Feb 6.


Molecular imaging of prostate cancer: a concise synopsis.

Jadvar H.

Mol Imaging. 2009 Mar-Apr;8(2):56-64. Review.


Phenotypic characterization of mice heterozygous for a null mutation of glutamate carboxypeptidase II.

Han L, Picker JD, Schaevitz LR, Tsai G, Feng J, Jiang Z, Chu HC, Basu AC, Berger-Sweeney J, Coyle JT.

Synapse. 2009 Aug;63(8):625-35. doi: 10.1002/syn.20649.


Moderate expression of prostate-specific membrane antigen, a tissue differentiation antigen and folate hydrolase, facilitates prostate carcinogenesis.

Yao V, Parwani A, Maier C, Heston WD, Bacich DJ.

Cancer Res. 2008 Nov 1;68(21):9070-7. doi: 10.1158/0008-5472.CAN-08-2328.


Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications.

Aartsma-Rus A, van Ommen GJ.

RNA. 2007 Oct;13(10):1609-24. Epub 2007 Aug 7. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk